
Cullen Capital Management significantly reduced its exposure to chemicals giant Dow (DOW) in Q2, divesting 1.36 million shares valued at $39.71 million. This transaction lowered Dow's position to 0.96% of Cullen's assets under management, removing it from their top five holdings. The move comes as Dow's stock has declined 58.1% over the past year, underperforming the S&P 500, amid struggles with negative net income, weak demand, pricing pressure, and high feedstock costs.
Cullen Capital Management's second-quarter sale of 1.36 million shares of Dow, valued at an estimated $39.71 million, represents a significant reduction in its conviction for the chemicals giant. This transaction has pushed Dow out of the firm's top five holdings, reducing its portfolio weight to just 0.96% of assets under management, although a notable stake of 3.2 million shares remains. The divestment coincides with severe pressure on Dow's equity, which has fallen 58.1% over the past year, starkly underperforming the S&P 500's nearly 16% gain. This performance reflects fundamental business headwinds, including weak demand, pricing pressure, and high feedstock costs, which have culminated in a trailing-twelve-month net loss of $981 million. While the stock's current 10.89% dividend yield is enticing, its sustainability is directly tied to an earnings recovery, making it a key risk factor for income-focused investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.60
Ticker Sentiment